SITES OF ACTION AND PHYSIOLOGICAL IMPACT OF MGLUR5 POSITIVE ALLOSTERIC MODULATORS
Positive allosteric modulators (PAMs) of metabotropic glutamate receptor subtype 5 (mGluR5) may provide a novel approach that could be useful in the treatment of certain central nervous system disorders. However, their physiological effects and pharmacological properties, such as sites of action, ar...
Main Author: | Chen, Yelin |
---|---|
Other Authors: | P.Jeffrey Conn |
Format: | Others |
Language: | en |
Published: |
VANDERBILT
2007
|
Subjects: | |
Online Access: | http://etd.library.vanderbilt.edu/available/etd-11072007-150603/ |
Similar Items
-
mGluR5 Positive Allosteric Modulation as a Novel Therapeutic Target for the Cognitive Deficits Associated with Schizophrenia
Published: (2014) -
Positive or negative allosteric modulation of metabotropic glutamate receptor 5 (mGluR5) does not alter expression of behavioral sensitization to methamphetamine [v1; ref status: indexed, http://f1000r.es/o0]
by: Peter R Kufahl, et al.
Published: (2013-03-01) -
4-Chlorophenylguanidine is an ASIC3 agonist and positive allosteric modulator
by: Amruta S. Agharkar, et al.
Published: (2017-03-01) -
Positive allosteric modulation of mGluR5 accelerates extinction learning but not relearning following methamphetamine self-administration
by: Peter R Kufahl, et al.
Published: (2012-11-01) -
Positive Allosteric Modulators of Type 5 Metabotropic Glutamate Receptors (mGluR5) and Their Therapeutic Potential for the Treatment of CNS Disorders
by: Richard M. Cleva, et al.
Published: (2011-03-01)